Innovo, a Wearable Device for Stress Urinary Incontinence, Now Available OTC
A wearable device to treat stress urinary incontinence, Innovo®, has been granted over-the-counter clearance by the Food and Drug Administration.
A wearable device to treat stress urinary incontinence, Innovo®, has been granted over-the-counter clearance by the Food and Drug Administration.
Continued surveillance necessary for patients with mesh implants for pelvic organ prolapse repair.
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
Pelvic physical therapy may be more appropriate than Kegel exercises in managing post-radical prostatectomy pain and stress urinary incontinence, according to a new study.
Long-term risks for reoperation, recurrence low in women treated for stress urinary incontinence.
Study concludes that few of the associated risk factors are modifiable and that clinicians should stress possible outcomes related to urinary dysfunction prior to patients receiving treatment for rectal cancer.
In a study, investigators did not observe a clinically important difference between midurethral sling surgery patients who did and did not receive perioperative behavioral therapies.
Proportion of apical procedures using transvaginal mesh decreased in year after safety communication
After a mean 9 years of follow-up, women who underwent tension-free vaginal tape obturator surgery for stress urinary incontinence had objective and subjective cure rates of 89% and 92%, respectively, a study found.
In a study, women undergoing a transobturator sling procedure had a 2.4-fold higher risk of reoperation for recurrent stress urinary incontinence than those undergoing a retropubic sling procedure.